These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 7097530)

  • 1. Plasma levels of a novel antidysrhythmic agent, meobentine sulfate, in humans as determined by radioimmunoassay.
    Warren JT; Coker GG; Welch RM; Fowle AS; Findlay JW
    J Pharm Sci; 1982 Jun; 71(6):665-70. PubMed ID: 7097530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antiarrhythmic activity of meobentine sulfate in man.
    Duff HJ; Oates JA; Roden DM; Woosley RL
    J Cardiovasc Pharmacol; 1984; 6(4):650-6. PubMed ID: 6206320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidysrhythmic actions of meobentine sulfate.
    Zimmerman JM; Patterson E; Pitt B; Lucchesi B
    Am Heart J; 1984 Jun; 107(6):1117-24. PubMed ID: 6720538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meobentine sulphate (bis[N-4-methoxybenzyl-N'N"-dimethylguanidine]sulphate): a new antidysrhythmic agent.
    Wastila WB; Copp FC; Walton E; Ellis CH; Maxwell RA
    J Pharm Pharmacol; 1981 Sep; 33(9):594-6. PubMed ID: 6117639
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on bethanidine and meobentine: direct and indirect effects of antifibrillatory drugs.
    Dangman KH; Wang HH; Reynolds RD
    J Cardiovasc Pharmacol; 1986; 8(6):1185-94. PubMed ID: 2434745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation.
    Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL
    Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay and pharmacokinetic profile of bupropion in the dog.
    Butz RF; Schroeder DH; Welch RM; Mehta NB; Phillips AP; Findlay JW
    J Pharmacol Exp Ther; 1981 Jun; 217(3):602-10. PubMed ID: 6785419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of guanabenz, an antihypertensive agent.
    Ohata K; Yokoyama N; Sakamoto H; Kohno S; Kobayashi M; Murai K; Kashima K; Tatsumi H
    Arzneimittelforschung; 1984; 34(12):1704-8. PubMed ID: 6543306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay.
    Walker DK; Aherne GW; Arrowsmith JE; Cross PE; Kaye B; Smith DA; Stopher DA; Wild W
    J Pharm Biomed Anal; 1991; 9(2):141-9. PubMed ID: 1873305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triprolidine radioimmunoassay: disposition in animals and humans.
    Findlay JW; Butz RF; Coker GG; DeAngelis RL; Welch RM
    J Pharm Sci; 1984 Oct; 73(10):1339-44. PubMed ID: 6502476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the effects of bethanidine, meobentine and quinidine on the electrical activity of rat hearts in vivo and in vitro.
    Northover BJ
    Br J Pharmacol; 1985 Mar; 84(3):755-63. PubMed ID: 3986433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromperidol radioimmunoassay: human plasma levels.
    Tischio J; Hetyei N; Patrick J
    J Pharm Sci; 1984 Apr; 73(4):546-8. PubMed ID: 6726642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aprikalim: radioimmunoassay and pharmacokinetic studies in mouse, monkey, and dog.
    Chevalier P; Rouillard C; Montay G; Frydman A
    J Pharm Sci; 1994 Mar; 83(3):372-8. PubMed ID: 8207684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dextromethorphan: radioimmunoassay and pharmacokinetics in the dog.
    Dixon R; Carbone JJ; Mohacsi E; Perry C
    Res Commun Chem Pathol Pharmacol; 1978 Nov; 22(2):243-55. PubMed ID: 734214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations.
    Wurzburger RJ; Miller RL; Marcum EA; Colburn WA; Spector S
    J Pharmacol Exp Ther; 1981 Jun; 217(3):757-63. PubMed ID: 7230004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a radioimmunoassay and its application to the pharmacokinetics of the stable prostacyclin analogue, nileprost, in the rat.
    Krause W; Nieuweboer B
    Prostaglandins Leukot Med; 1984 Apr; 14(1):1-9. PubMed ID: 6374676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of the anti-hypertensive agent debrisoquin.
    Dixon R; Fahrenholtz KE; Burger W; Perry
    Res Commun Chem Pathol Pharmacol; 1977 Jan; 16(1):121-9. PubMed ID: 557221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereospecific radioimmunoassays for d-pseudoephedrine in human plasma and their application to bioequivalency studies.
    Findlay JW; Warren JT; Hill JA; Welch RM
    J Pharm Sci; 1981 Jun; 70(6):624-31. PubMed ID: 7252804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and application of a specific radioimmunoassay for trifluoperazine N4'-oxide to a kinetic study in humans.
    Aravagiri M; Hawes EM; Midha KK
    J Pharmacol Exp Ther; 1986 May; 237(2):615-22. PubMed ID: 3701645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioimmunoassay for the 7-hydroxy metabolite of trifluoperazine and its application to a kinetic study in human volunteers.
    Aravagiri M; Hawes EM; Midha KK
    J Pharm Sci; 1985 Nov; 74(11):1196-202. PubMed ID: 4087181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.